Last reviewed · How we verify
NCT06368297
The Effect of Ketone Ester Supplementation and Ketogenic Diet on Brain Plasticity in Overweight/Obese Adults: A Neurophysiological and Resting Functional Magnetic Resonance Study (rfMRI)
NA trial testing Ketone Monoester Supplementation in Overweight and Obesity in 40 participants. Status unknown.
1 August 2024
Quick facts
| Lead sponsor | University of Macau |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 40 |
| Start date | 1 April 2024 |
| Primary completion | 1 August 2024 |
| Estimated completion | 1 August 2024 |
Drugs / interventions tested
- Ketone Monoester Supplementation
- Ketogenic diet — full drug profile →
Conditions studied
- Overweight and Obesity — all drugs for Overweight and Obesity →
- Cognitive Change — all drugs for Cognitive Change →
- Psychophysiologic Reaction — all drugs for Psychophysiologic Reaction →
Sponsor
University of Macau
Who can join
Adults 20 to 50, any sex, with Overweight and Obesity or Cognitive Change. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Brain Plasticity
Time frame: 2 weeks
This measurement is "brain plasticity". Brain plasticity, also known as neuroplasticity, refers to the brain's remarkable ability to change and adapt in response to experience. The brain plasticity will be measured by transcranial magnetic stimulation (TMS) system. When assessing brain plasticity using TMS through the measurement of Motor Evoked Potentials (MEPs), the primary unit of measurement i -
Grey Matter Volume
Time frame: 2 weeks
The measurement name is "grey matter volume", which belongs to brain structure. The grey matter volume will be assessed by the magnetic resonance imaging system. Grey matter volume is generally measured in cubic centimeters (cm³) or milliliters (mL), as both units are equivalent in volume measurement (1 cm³ = 1 mL). This measure reflects the volume of grey matter regions in the brain, which includ -
Cortical Thickness
Time frame: 2 weeks
The measurement name is "cortical thickness", which belongs to brain structure. The cortical thickness will be assessed by the magnetic resonance imaging system. Cortical thickness is measured in millimeters (mm). It refers to the average thickness of the grey matter cortex across various regions of the brain. Cortical thickness can vary significantly across different parts of the cortex, typicall -
Blood-Oxygen-Level-Dependent (BOLD) Signal Changes
Time frame: 2 weeks
The measurement name is "Blood-Oxygen-Level-Dependent (BOLD) Signal Changes", which belongs to brain function. The cortical thickness will be assessed by the magnetic resonance imaging system (MRI). The unit of BOLD signal changes measured by MRI is typically expressed as a percentage change (%). The BOLD signal reflects changes in the magnetic properties of blood due to variations in oxygenation
Sponsor's own description
This project comprises an initial crossover placebo-controlled neurophysiological study to ascertain the effect of acute ketone ester ingestion on motor cortex plasticity, followed by a second 2-week intervention study aimed to compare the effect of a ketogenic diet versus ketone ester supplementation on motor cortex plasticity, resting brain function and structure, and metabolic and neuroendocrine responses.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Acute ketone monoester supplementation in young adults: modulating metabolic and neurocognitive functions across body weights.
Yu Q, Wong KK, Lei OK, Armada-da-Silva PAS, et al · · 2025 · cited 1× · PMID 39418669 · DOI 10.1139/apnm-2024-0229
Verify or expand the search:
- PubMed search for NCT06368297
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overweight and Obesity
Currently open trials in the same condition.
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
- NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
Other University of Macau trials
Trials by the same sponsor.
- NCT07342816 — Impact of Mindfulness on Athletic Performance and Functional Movement in Collegiate Athletes · NA · recruiting
- NCT07347717 — Digital Self-Compassion Writing Intervention to Support Mental Health of Parents of Autistic Individuals · NA · active not recruiting
- NCT07157566 — From Health Information to Health Decisions Integrating Mindfulness Into Digital Learning and Daily Life · NA · recruiting
- NCT07408284 — Yo-Yo With Ball and Small-Sided Games Intervention · NA · completed
- NCT06813625 — Shared Book Reading to Promote Mental Well-being Among Young People with and Without Down's Syndrome · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06368297 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Macau
- Last refreshed: 10 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06368297.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing